KRAS and pancreatic neoplasm: Interestingly, AMD3100 reduced the proliferation of Hs766t, a CXCL12+ KRAS wild-type (WT) pancreatic tumor cell line, suggesting an autocrine regulatory loop that may be at play in some pancreatic tumors [39].